Nativis, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Nativis, Inc. - overview
Established
2002
Location
Seattle, WA, US
Primary Industry
Biotechnology
About
Nativis, Inc. specializes in innovative branding solutions, providing a platform for domain name acquisition and related services that help businesses establish a strong online identity. Founded in 2002, Nativis, Inc. is based in Seattle, US, and is focused on offering domain name acquisition and branding solutions.
The company has completed 7 deals, with its most recent deal occurring on November 10, 2017, when it raised USD 1 million in venture funding. The current CEO is Annick Lema, alongside Chris Rivera. Nativis operates through its platform Atom. com, providing a comprehensive suite of services for domain name acquisition and branding.
It features a marketplace with over 300,000 expert-curated domains, allowing businesses to discover brandable domain names that fit their identity. Nativis also offers AI-powered tools for name generation, logo creation, and trademark services, catering to a global clientele across North America, Europe, and Asia. In the most recent year of 2021, Nativis reported a revenue of USD 241,000. The company operates through direct-to-consumer sales, offering domain names and related services, while also providing trademark validation and filing services through licensed attorneys.
The pricing structure accommodates various client needs, with a focus on user engagement and support for branding efforts. Nativis aims to leverage its recent funding of USD 1 million raised in November 2017 to enhance its platform and expand its service offerings. The company is exploring the development of new products aimed at improving user experience in branding, and it plans to expand its reach into new markets by targeting clients in emerging economies by 2025. This strategic approach will enable Nativis to strengthen its position in the domain acquisition and branding industry.
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy
Website
www.nativis.com
Company Stage
Series A
Total Amount Raised
Subscriber access only

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.